Market Closed -
Other stock markets
|
After market 19:59:33 | |||
7 EUR | +5.11% | 7.005 | +0.07% |
04-17 | OSE: licensing agreement with AbbVie enters into force | CF |
04-17 | OSE Immunotherapeutics Finalizes Drug License, Collaboration Deal With AbbVie | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+63.55% | 154M | |
+24.21% | 46.71B | |
+48.83% | 41.8B | |
-0.92% | 41.52B | |
-5.86% | 29.55B | |
+11.11% | 25.78B | |
-20.47% | 19.26B | |
+2.85% | 12.14B | |
-3.22% | 12.08B | |
+30.44% | 11.98B |
- Stock Market
- Equities
- OSE Stock
- News OSE Immunotherapeutics
- Ose Immunotherapeutics, GenDx to Co-develop Diagnostic Test Companion for Cancer Vaccine Trial